Inorganic Arsenic and Human Prostate Cancer
2008

Inorganic Arsenic and Human Prostate Cancer

publication Evidence: moderate

Author Information

Author(s): Benbrahim-Tallaa Lamia, Waalkes Michael P.

Primary Institution: National Cancer Institute at the National Institute of Environmental Health Sciences

Hypothesis

We critically evaluated the etiologic role of inorganic arsenic in human prostate cancer.

Conclusion

Available evidence in human populations and human cells in vitro indicates that the prostate is a target for inorganic arsenic carcinogenesis.

Supporting Evidence

  • Multiple studies in humans reveal an association between environmental inorganic arsenic exposure and prostate cancer mortality or incidence.
  • Many human studies provide clear evidence of a dose–response relationship.
  • Arsenic exposure is linked to increased mortality from prostate cancer in areas with high arsenic levels in drinking water.

Takeaway

Arsenic, a common contaminant in drinking water, may cause prostate cancer in humans, especially in areas with high exposure.

Methodology

The study assessed data from epidemiologic studies and in vitro models regarding arsenic exposure and prostate cancer.

Potential Biases

Potential ecological fallacy in interpreting village-level data as individual-level risk.

Limitations

The study lacks whole animal models specifically showing prostate cancer as a target for arsenic.

Participant Demographics

The studies primarily involved populations from Taiwan and the U.S. with varying levels of arsenic exposure.

Statistical Information

Confidence Interval

95% CI, 1.4–2.6

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1289/ehp.10423

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication